<br />
HEMATOLOGY<br />
EMJ Hematol. 2017 Suppl 11 • europeanmedical-journal.com<br />
INSIDE<br />
β-Thalassaemias: Highlights from the<br />
European Hematology Association<br />
Scientific Working Group (EHA-SWG)<br />
Scientific Meeting on Anaemias:<br />
Diagnosis and Treatment in the Omics Era<br />
1<br />
β-THALASSAEMIAS: HIGHLIGHTS<br />
FROM THE EUROPEAN HEMATOLOGY<br />
ASSOCIATION SCIENTIFIC WORKING GROUP<br />
(EHA-SWG) SCIENTIFIC MEETING ON ANAEMIAS:<br />
DIAGNOSIS AND TREATMENT IN THE OMICS ERA<br />
This article comprises a summary of scientific sessions on<br />
β-thalassaemia that took place on 2nd–4th February 2017,<br />
as part of the European Hematology Association Scientific<br />
Working Group meeting: Anaemias: Diagnosis and Treatment<br />
in the Omics Era, in Barcelona, Spain<br />
Chairpersons and speakers<br />
Clara Camaschella,1,2 Ali T. Taher,3 Maria-Domenica Cappellini4,5<a title="EMJ Hematol. 2017 Suppl 11 page 1" href="http://viewer.zmags.com/publication/4344a328?page=1"> HEMATOLOGY EMJ Hematol. 2017 Suppl 11 • europeanm</a>
<a title="EMJ Hematol. 2017 Suppl 11 page 2" href="http://viewer.zmags.com/publication/4344a328?page=2"> β-THALASSAEMIAS: HIGHLIGHTS </a>
<a title="EMJ Hematol. 2017 Suppl 11 page 3" href="http://viewer.zmags.com/publication/4344a328?page=3"> is most common in East India, Bangladesh, a</a>
<a title="EMJ Hematol. 2017 Suppl 11 page 4" href="http://viewer.zmags.com/publication/4344a328?page=4"> β-thalassaemia Free α-gl</a>
<a title="EMJ Hematol. 2017 Suppl 11 page 5" href="http://viewer.zmags.com/publication/4344a328?page=5"> system, resulting in iron overload and toxicity i</a>
<a title="EMJ Hematol. 2017 Suppl 11 page 6" href="http://viewer.zmags.com/publication/4344a328?page=6"> Use of DFO has reduced significantly since the int</a>
<a title="EMJ Hematol. 2017 Suppl 11 page 7" href="http://viewer.zmags.com/publication/4344a328?page=7"> of pulmonary hypertension, and increased liv</a>
<a title="EMJ Hematol. 2017 Suppl 11 page 8" href="http://viewer.zmags.com/publication/4344a328?page=8"> The most difficult phase in the development of ge</a>
<a title="EMJ Hematol. 2017 Suppl 11 page 9" href="http://viewer.zmags.com/publication/4344a328?page=9"> must be tailored to the individual patient’s need</a>
<a title="EMJ Hematol. 2017 Suppl 11 page 10" href="http://viewer.zmags.com/publication/4344a328?page=10"> 43. Shirley M, Plosker GL. Deferasirox: a review</a>